These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17348121)

  • 1. Adjuvant docetaxel-based treatment for breast cancer.
    Tilstone C
    Lancet Oncol; 2007 Jan; 8(1):15. PubMed ID: 17348121
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of docetaxel in the adjuvant chemotherapy of breast cancer].
    Fattoruso SI; Rossi S; Di Lauro L; Botti C; Vici P; Lopez M
    Clin Ter; 2008; 159(5):369-76. PubMed ID: 18998039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Docetaxel in the inductive therapy of head and neck cancer: recent evidence].
    Benasso M; Corvò R
    Tumori; 2008; 94(4):suppl 24-5. PubMed ID: 18822713
    [No Abstract]   [Full Text] [Related]  

  • 4. Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer.
    Bellon JR; Lindsley KL; Ellis GK; Gralow JR; Livingston RB; Austin Seymour MM
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):393-7. PubMed ID: 10974452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taxanes in the adjuvant treatment of breast cancer.
    Trauth D; Goldstein LJ
    J Natl Compr Canc Netw; 2003 Apr; 1(2):222-31. PubMed ID: 19768881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer.
    Heys SD; Sarkar T; Hutcheon AW
    Expert Opin Pharmacother; 2004 Oct; 5(10):2147-57. PubMed ID: 15461550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The best use of chemotherapy in the adjuvant setting.
    Cardoso F; Piccart MJ
    Breast; 2003 Dec; 12(6):522-8. PubMed ID: 14659130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel and adjuvant treatment of breast cancer.
    Prescrire Int; 2011 Jun; 20(117):149. PubMed ID: 21678701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Have we reached a plateau in adjuvant breast cancer therapy?
    Codacci-Pisanelli G; Spinelli GP; Peccatori FA
    Lancet; 2009 Oct; 374(9699):1421. PubMed ID: 19854372
    [No Abstract]   [Full Text] [Related]  

  • 11. [The viewpoint of the medical oncologist].
    Benasso M
    Tumori; 2008; 94(4):suppl 26-9. PubMed ID: 18822714
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and toxicity of preoperative chemotherapy with docetaxel and epirubicin in locally advanced invasive breast cancer.
    Kaya AO; Coskun U; Buyukberber S; Benekli M; Tekin E; Cifter C; Ozturk B; Yildiz R; Yaman E; Uner A; Yamac D
    J BUON; 2010; 15(2):248-54. PubMed ID: 20658717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of Taxotere in adjuvant chemotherapy of breast cancer].
    Besova NS
    Vopr Onkol; 2011; 57(5):651-7. PubMed ID: 22238938
    [No Abstract]   [Full Text] [Related]  

  • 14. Colored body images reveal the perceived intensity and distribution of pain in women with breast cancer treated with adjuvant taxanes: a prospective multi-method study of pain experiences.
    Hellerstedt-Börjesson S; Nordin K; Fjällskog ML; Rissanen R; Peterson M; Arving C
    Scand J Pain; 2018 Oct; 18(4):581-591. PubMed ID: 29949517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of docetaxel for breast cancer.
    Lwin Z; Leighl N
    Expert Opin Pharmacother; 2009 Feb; 10(2):283-90. PubMed ID: 19236199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
    Kibel AS; Rosenbaum E; Kattan MW; Picus J; Dreicer R; Klein EA; Chatta GS; Nelson JB; DiPaola RS; Roth BJ; Cookson MS; Wilding G; Jarrard DF; Beer TM; Ryan CW; Petrylak DP; Benson MC; Partin AW; Garrett-Mayer E; Eisenberger MA
    J Urol; 2007 May; 177(5):1777-81. PubMed ID: 17437819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of docetaxel on developing oedema in patients with breast cancer: a systematic review.
    Hugenholtz-Wamsteker W; Robbeson C; Nijs J; Hoelen W; Meeus M
    Eur J Cancer Care (Engl); 2016 Mar; 25(2):269-79. PubMed ID: 25348689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of docetaxel (Taxotere) as second-line chemotherapy in patients with metastatic breast cancer.
    Baur M; van Oosterom AT; Diéras V; Tubiana-Hulin M; Coombes RC; Hatschek T; Murawsky M; Klink-Alakl M; Hudec M; Dittrich C
    J Cancer Res Clin Oncol; 2008 Feb; 134(2):125-35. PubMed ID: 17636328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancer.
    Estévez LG; Gradishar WJ
    Clin Cancer Res; 2004 May; 10(10):3249-61. PubMed ID: 15161677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant taxanes: more to the story.
    Gajria D; Seidman A; Dang C
    Clin Breast Cancer; 2010 Sep; 10 Suppl 2():S41-9. PubMed ID: 20805064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.